Business Case

Defined the key requirements for novel GTx entry and regional access to inform regional access strategies and planned activities and further organizational alignment initiatives

The Italian local team of a small gene therapy company was interested in understanding the requirements for entry and regional access for a novel GTx therapy. LSC initiated a multi-phased approach, initiated by stakeholder engagement, to collect valuable feedback on key requirements, then proceeded to review and incorporate findings into regional access strategies and prepared cross-functional insights for critical policy initiatives. Through these processive, systematic phases, we aided the company in refining their regional access strategies, aligning organizational activities and strengthening their deployment.